Trends in Rationalized Brain Targeted Nanoparticles in Neurological Disorders (Part-III)

Curr Drug Metab. 2021;22(4):250. doi: 10.2174/138920022204210517114829.

Authors

Md Noushad Javed¹, Ghulam Md Ashraf², George E Barreto³, Mohd Javed Naim⁴

Affiliations

¹ Department of Pharmaceutics, School of Pharmaceutical Sciences, Apeejay Stya University, Gurugram, India.
² Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
³ Department of Biological Sciences, University of Limerick, Limerick, Ireland.
⁴ Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Shivdan Singh Institute of Technology and Management (SSITM), India.

PMID: 34170805
DOI: 10.2174/138920022204210517114829

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Blood-Brain Barrier / metabolism
Central Nervous System Agents / administration & dosage*
Humans
Nanoparticle Drug Delivery System / pharmacology*
Nervous System Diseases / drug therapy*

Substances

Central Nervous System Agents
Nanoparticle Drug Delivery System